1,840 Shares in Septerna, Inc. (NASDAQ:SEPN) Acquired by Legal & General Group Plc

Legal & General Group Plc purchased a new position in Septerna, Inc. (NASDAQ:SEPN) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 1,840 shares of the company’s stock, valued at approximately $42,000.

Several other hedge funds and other institutional investors have also bought and sold shares of SEPN. New York State Common Retirement Fund purchased a new stake in Septerna during the 4th quarter valued at about $32,000. PNC Financial Services Group Inc. acquired a new position in Septerna in the 4th quarter worth approximately $61,000. SG Americas Securities LLC purchased a new position in Septerna during the 4th quarter worth approximately $185,000. Corebridge Financial Inc. purchased a new stake in shares of Septerna in the 4th quarter valued at $212,000. Finally, Wells Fargo & Company MN purchased a new position in shares of Septerna during the fourth quarter worth $244,000.

Insider Buying and Selling

In other Septerna news, CFO Gil M. Labrucherie purchased 10,500 shares of the business’s stock in a transaction that occurred on Wednesday, February 19th. The shares were purchased at an average price of $5.51 per share, for a total transaction of $57,855.00. Following the completion of the acquisition, the chief financial officer now owns 10,500 shares of the company’s stock, valued at approximately $57,855. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Alan Ezekowitz acquired 41,355 shares of the stock in a transaction on Thursday, March 6th. The stock was purchased at an average cost of $6.00 per share, with a total value of $248,130.00. Following the transaction, the director now directly owns 104,101 shares of the company’s stock, valued at $624,606. This represents a 65.91 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last 90 days, insiders have bought 74,346 shares of company stock worth $439,670.

Septerna Stock Performance

Shares of SEPN stock opened at $7.14 on Friday. The business’s 50-day moving average price is $6.06. Septerna, Inc. has a 1 year low of $4.17 and a 1 year high of $28.99.

Septerna (NASDAQ:SEPN) last issued its quarterly earnings results on Thursday, March 27th. The company reported ($0.64) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.69) by $0.05. The firm had revenue of $0.21 million for the quarter, compared to analyst estimates of $0.13 million. Analysts predict that Septerna, Inc. will post -7.11 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SEPN. Wells Fargo & Company decreased their target price on shares of Septerna from $14.00 to $11.00 and set an “equal weight” rating for the company in a research note on Friday, March 28th. Cantor Fitzgerald reissued an “overweight” rating and issued a $50.00 price target on shares of Septerna in a research note on Tuesday, February 11th.

Septerna Company Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.